189 related articles for article (PubMed ID: 36914856)
1. Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in Tau
Lim S; Shin S; Sung Y; Lee HE; Kim KH; Song JY; Lee GH; Aziz H; Lukianenko N; Kang DM; Boesen N; Jeong H; Abdildinova A; Lee J; Yu BY; Lim SM; Lee JS; Ryu H; Pae AN; Kim YK
Exp Mol Med; 2023 Mar; 55(3):612-627. PubMed ID: 36914856
[TBL] [Abstract][Full Text] [Related]
2. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo.
Violet M; Chauderlier A; Delattre L; Tardivel M; Chouala MS; Sultan A; Marciniak E; Humez S; Binder L; Kayed R; Lefebvre B; Bonnefoy E; Buée L; Galas MC
Neurobiol Dis; 2015 Oct; 82():540-551. PubMed ID: 26385829
[TBL] [Abstract][Full Text] [Related]
3. Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy.
Shin S; Kim D; Song JY; Jeong H; Hyeon SJ; Kowall NW; Ryu H; Pae AN; Lim S; Kim YK
Prog Neurobiol; 2020 Feb; ():101782. PubMed ID: 32105751
[TBL] [Abstract][Full Text] [Related]
4. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
5. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
[TBL] [Abstract][Full Text] [Related]
6. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099
[TBL] [Abstract][Full Text] [Related]
7. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
8. TOC1: a valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy.
Ward SM; Himmelstein DS; Ren Y; Fu Y; Yu XW; Roberts K; Binder LI; Sahara N
Neurobiol Dis; 2014 Jul; 67():37-48. PubMed ID: 24631720
[TBL] [Abstract][Full Text] [Related]
9. MK-8719, a Novel and Selective
Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy.
Zheng J; Akbari M; Schirmer C; Reynaert ML; Loyens A; Lefebvre B; Buée L; Croteau DL; Galas MC; Bohr VA
Acta Neuropathol Commun; 2020 Mar; 8(1):25. PubMed ID: 32131898
[TBL] [Abstract][Full Text] [Related]
11. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
13. Functional Selection of Tau Oligomerization-Inhibiting Aptamers.
Wang B; Pan X; Teng IT; Li X; Kobeissy F; Wu ZY; Zhu J; Cai G; Yan H; Yan X; Liang M; Yu F; Lu J; Yang Z; Biondi E; Haskins W; Cao YC; Benner SA; Tan W; Wang KK
Angew Chem Int Ed Engl; 2024 Apr; 63(18):e202402007. PubMed ID: 38407551
[TBL] [Abstract][Full Text] [Related]
14. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
[TBL] [Abstract][Full Text] [Related]
15. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
16. Tau oligomers as potential targets for early diagnosis of tauopathy.
Sahara N; Ren Y; Ward S; Binder LI; Suhara T; Higuchi M
J Alzheimers Dis; 2014; 40 Suppl 1():S91-6. PubMed ID: 24595194
[TBL] [Abstract][Full Text] [Related]
17. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
DeVos SL; Miller RL; Schoch KM; Holmes BB; Kebodeaux CS; Wegener AJ; Chen G; Shen T; Tran H; Nichols B; Zanardi TA; Kordasiewicz HB; Swayze EE; Bennett CF; Diamond MI; Miller TM
Sci Transl Med; 2017 Jan; 9(374):. PubMed ID: 28123067
[TBL] [Abstract][Full Text] [Related]
18. Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies.
Lo CH; Lim CK; Ding Z; Wickramasinghe SP; Braun AR; Ashe KH; Rhoades E; Thomas DD; Sachs JN
Alzheimers Dement; 2019 Nov; 15(11):1489-1502. PubMed ID: 31653529
[TBL] [Abstract][Full Text] [Related]
19. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
20. The use of mouse models to study cell-to-cell transmission of pathological tau.
Narasimhan S; Lee VMY
Methods Cell Biol; 2017; 141():287-305. PubMed ID: 28882308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
